Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature.

Classical and molecular cytogenetic analysis, including fluorescence in situ hybridization (FISH) and chromosomal comparative genomic hybridization (CGH), were used to examine genetic changes involved in the development and/or progression of oral squamous cell carcinoma (OSCC). Of 31 OSCC cell lines studied, more than one-third expressed clonal structural abnormalities involving chromosomes 3, 7, 8, 9, and 11. Eleven OSCC cell lines were evaluated using CGH to identify novel genome-wide gains, losses, or amplifications. By CGH, more than half of the cell lines showed loss of 3p, gain of 3q, 8q, and 20q. Further, molecular cytogenetic analyses by FISH of primary tumors showed that the karyotypes of cell lines derived from those tumors correlated with specific gains and losses in the tumors from which they were derived. The most frequent nonrandom aberration identified by both karyotype and CGH analyses was amplification of chromosomal band 11q13 in the form of a homogeneously staining region. Our data suggest that loss of 9p and 11q13 amplification may be of prognostic benefit in the management of OSCC, which is consistent with the literature. The results of this study validate the relationship between these OSCC cell lines and the tumors from which they were derived. The results also emphasize the usefulness of these cell lines as in vitro experimental models and provide important genetic information on these OSCC cell lines that were recently reported in this journal.

[1]  A. Neugut,et al.  A comparison of the clinical characteristics of first and second primary head and neck cancers. A population‐based study , 1991, Cancer.

[2]  R. Day,et al.  Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival , 1998 .

[3]  W. Hong,et al.  Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification , 1998, Oncogene.

[4]  P. Platzer,et al.  Microenvironmental genomic alterations and clinicopathological behavior in head and neck squamous cell carcinoma. , 2007, JAMA.

[5]  J. Wilson,et al.  Cyclins, cyclin-dependent kinases, cyclin-dependent kinase inhibitors and their role in head and neck cancer. , 1998, Clinical otolaryngology and allied sciences.

[6]  Irene L Andrulis,et al.  MADR2 Maps to 18q21 and Encodes a TGFβ–Regulated MAD–Related Protein That Is Functionally Mutated in Colorectal Carcinoma , 1996, Cell.

[7]  B. Tilley,et al.  Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region , 1994, Genes, chromosomes & cancer.

[8]  T. Nakashima,et al.  Identification and cDNA cloning of headpin, a novel differentially expressed serpin that maps to chromosome 18q. , 1999, Biochemical and biophysical research communications.

[9]  S. Gollin,et al.  Visualization of INT2 and HST1 Amplification in oral squamous cell carcinomas , 1995, Genes, chromosomes & cancer.

[10]  K. Tanimoto,et al.  Abnormalities of the FHIT gene in human oral carcinogenesis , 2000, British Journal of Cancer.

[11]  J. Fridlyand,et al.  Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma , 2005, Oncogene.

[12]  A. Jemal,et al.  Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.

[13]  T. Nakashima,et al.  Genomic cloning, mapping, structure and promoter analysis of HEADPIN, a serpin which is down-regulated in head and neck cancer cells. , 2000, Biochimica et biophysica acta.

[14]  High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: impact of copy number on gene expression. , 2004 .

[15]  I. Petersen,et al.  Chromosomal instability and cytoskeletal defects in oral cancer cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Batsakis,et al.  Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma. , 1995, Cancer research.

[17]  Iscn International System for Human Cytogenetic Nomenclature , 1978 .

[18]  S. Gollin,et al.  Relationship between FRA11F and 11q13 gene amplification in oral cancer , 2007, Genes, chromosomes & cancer.

[19]  P. Lichter,et al.  Candidate genes in breast cancer revealed by microarray-based comparative genomic hybridization of archived tissue. , 2005, Cancer research.

[20]  M. Hendrix,et al.  Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. , 1994, Science.

[21]  A. Read,et al.  Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma of the oral cavity. , 1994, Cancer research.

[22]  G. Pruneri,et al.  Molecular and immunohistochemical analysis of the bcl‐1/cyclin D1 gene in laryngeal squamous cell carcinomas , 1997, Cancer.

[23]  T. Godfrey,et al.  Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma , 2006, Genes, chromosomes & cancer.

[24]  Xin Huang,et al.  High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  F. Bosch,et al.  PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. , 1994, Cancer research.

[26]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[27]  F. Mitelman,et al.  Nonrandom chromosome abnormalities in short-term cultured primary squamous cell carcinomas of the head and neck. , 1995, Cancer research.

[28]  C. Croce,et al.  FHIT gene alterations in head and neck squamous cell carcinomas. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Gollin,et al.  Chromosomal instability and marker chromosome evolution in oral squamous cell carcinoma , 2004, Genes, chromosomes & cancer.

[30]  J. Stephenson,et al.  Murine leukemia virus mutants with temperature-sensitive defects in precursor polypeptide cleavage , 1975, Cell.

[31]  F. Mertens,et al.  Cytogenetic abnormalities in 106 oral squamous cell carcinomas. , 2006, Cancer genetics and cytogenetics.

[32]  F. Mitelman,et al.  Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck , 1995, Cancer.

[33]  J. Shah,et al.  Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  F. Mertens,et al.  Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression , 1997, Cancer.

[35]  L. Goodrich,et al.  Duplication of ATR inhibits MyoD, induces aneuploidy and eliminates radiation-induced G1 arrest , 1998, Nature Genetics.

[36]  R. Hruban,et al.  Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. , 1994, Cancer research.

[37]  J. Califano,et al.  11:40 AM: A Genetic Progression Model for Head and Neck Cancer: Implications for Field Cancerization , 1996 .

[38]  J. Grandis,et al.  Head and neck squamous cell carcinoma cell lines: Established models and rationale for selection , 2007, Head & neck.

[39]  T. Ried,et al.  H2AX Haploinsufficiency Modifies Genomic Stability and Tumor Susceptibility , 2003, Cell.

[40]  C. R. Leemans,et al.  A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. , 2003, Cancer research.

[41]  M. Oshimura,et al.  Functional evidence for involvement of multiple putative tumor suppressor genes on the short arm of chromosome 3 in human oral squamous cell carcinogenesis. , 1998, Cancer genetics and cytogenetics.

[42]  M. Welters,et al.  Centromeric breakage as a major cause of cytogenetic abnormalities in oral squamous cell carcinoma , 1996, Genes, chromosomes & cancer.

[43]  P. Lichter,et al.  Recurrent coamplification of cytoskeleton‐associated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinoma , 2006, Genes, chromosomes & cancer.

[44]  P. Mieczkowski,et al.  The Pattern of Gene Amplification Is Determined by the Chromosomal Location of Hairpin-Capped Breaks , 2006, Cell.

[45]  T. Carey,et al.  Loss of chromosome arm 18q with tumor progression in head and neck squamous cancer , 2004, Genes, chromosomes & cancer.

[46]  D. Ward,et al.  Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. , 1995, Cancer research.

[47]  A. Hart,et al.  Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. , 1995, Cancer research.

[48]  M. L. Le Beau,et al.  A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage‐fusion‐bridge cycle model for 11q13 amplification , 2000, Genes, chromosomes & cancer.

[49]  F. Latif,et al.  Detailed genetic and physical map of the 3p chromosome region surrounding the familial renal cell carcinoma chromosome translocation, t(3;8)(p14.2;q24.1). , 1993, Cancer research.

[50]  T. Gilmer,et al.  Oncogene amplification in squamous cell carcinoma of the head and neck. , 1990, Archives of otolaryngology--head & neck surgery.

[51]  K. Somers,et al.  Amplification of the int-2 gene in human head and neck squamous cell carcinomas. , 1990, Oncogene.

[52]  I. Bièche,et al.  Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[53]  R. Weichselbaum,et al.  Cytogenetic evidence of the multistep origin of head and neck squamous cell carcinomas. , 1992, Journal of the National Cancer Institute.

[54]  S. Gollin Chromosomal alterations in squamous cell carcinomas of the head and neck: Window to the biology of disease , 2001, Head & neck.

[55]  David I. Smith,et al.  A role for common fragile site induction in amplification of human oncogenes. , 2002, Cancer cell.

[56]  F. Mertens,et al.  Chromosome abnormalities in oral squamous cell carcinomas. , 1993, European journal of cancer. Part B, Oral oncology.

[57]  K. Hörmann,et al.  Fhit expression is absent or reduced in a subset of primary head and neck cancer. , 2000, Anticancer Research.

[58]  Jorma Isola,et al.  Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization. , 2003, Cancer research.

[59]  J. Jen,et al.  AIS is an oncogene amplified in squamous cell carcinoma. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[60]  T. Glover,et al.  Mechanisms of common fragile site instability. , 2005, Human molecular genetics.

[61]  Scott E. Kern,et al.  DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.

[62]  Lesley Seymour,et al.  Erlotinib in lung cancer - molecular and clinical predictors of outcome. , 2005, The New England journal of medicine.

[63]  H. Moch,et al.  Tissue microarrays for gene amplification surveys in many different tumor types. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[64]  O. Kallioniemi,et al.  Identification of target genes in laryngeal squamous cell carcinoma by high-resolution copy number and gene expression microarray analyses , 2006, Oncogene.

[65]  Kathleen R. Cho,et al.  Identification of a chromosome 18q gene that is altered in colorectal cancers. , 1990, Science.

[66]  R. Ferrell,et al.  Loss of heterozygosity of the short arm of chromosomes 3 and 9 in oral cancer , 1996, International journal of cancer.

[67]  V. Wreesmann,et al.  Chromosomal aberrations in squamous cell carcinomas of the upper aerodigestive tract: biologic insights and clinical opportunities. , 2005, Journal of Oral Pathology & Medicine.

[68]  E. Schuuring,et al.  Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. , 1992, Oncogene.

[69]  R. Zarbo,et al.  Chromosomal aberrations identified in culture of squamous carcinomas are confirmed by fluorescence in situ hybridisation. , 1999, Molecular pathology : MP.

[70]  F. Alt,et al.  Histone H2AX A Dosage-Dependent Suppressor of Oncogenic Translocations and Tumors , 2003, Cell.

[71]  S. Gollin Mechanisms leading to chromosomal instability. , 2005, Seminars in cancer biology.

[72]  R. Maestro,et al.  Three discrete regions of deletion at 3p in head and neck cancers. , 1993, Cancer research.

[73]  Amplification and expression of EMS-1 (cortactin) in head and neck squamous cell carcinoma cell lines. , 1996, Oncogene.

[74]  Mattias Höglund,et al.  Frequent amplification of 8q24, 11q, 17q, and 20q‐specific genes in pancreatic cancer , 2002, Genes, chromosomes & cancer.

[75]  A. Bernheim,et al.  Initiation of the breakage-fusion-bridge mechanism through common fragile site activation in human breast cancer cells: the model of PIP gene duplication from a break at FRA7I. , 2002, Human molecular genetics.

[76]  M. Romkes,et al.  Loss of distal 11q is associated with DNA repair deficiency and reduced sensitivity to ionizing radiation in head and neck squamous cell carcinoma , 2007, Genes, chromosomes & cancer.

[77]  M. Höglund,et al.  FISH characterization of head and neck carcinomas reveals that amplification of band 11q13 is associated with deletion of distal 11q , 1998, Genes, chromosomes & cancer.

[78]  W. Lam,et al.  3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites. , 2002, Cancer research.

[79]  A. Read,et al.  Allelic imbalance on chromosome 3p in oral dysplastic lesions: an early event in oral carcinogenesis. , 1996, Cancer research.

[80]  I. Petersen,et al.  Chromosomal alterations during metastasis formation of head and neck squamous cell carcinoma , 2002, Genes, chromosomes & cancer.

[81]  D. Gordenin,et al.  The Mre11 Complex Is Required for Repair of Hairpin-Capped Double-Strand Breaks and Prevention of Chromosome Rearrangements , 2002, Cell.

[82]  K. Kok,et al.  High-resolution mapping identifies a commonly amplified 11q13.3 region containing multiple genes flanked by segmental duplications , 2007, Human Genetics.

[83]  B. Houle,et al.  Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[84]  C. Martin,et al.  The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines. , 2007, Oral oncology.

[85]  G. Kong,et al.  Comparative genomic hybridization analysis reveals 3q gain resulting in genetic alteration in 3q in advanced oral squamous cell carcinoma. , 2001, Cancer genetics and cytogenetics.

[86]  T. Carey,et al.  Nonrandom chromosome aberrations and clonal populations in head and neck cancer. , 1993, Anticancer research.

[87]  A. Jemal,et al.  Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.

[88]  E. Feingold,et al.  Inverted duplication pattern in anaphase bridges confirms the breakage-fusion-bridge (BFB) cycle model for 11q13 amplification , 2007, Cytogenetic and Genome Research.

[89]  T. Glover,et al.  Positional cloning of the hereditary renal carcinoma 3;8 chromosome translocation breakpoint. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[90]  J. Yokota,et al.  Human HST1 (HSTF1) gene maps to chromosome band 11q13 and coamplifies with the INT2 gene in human cancer. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[91]  J W Gray,et al.  Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[92]  G. Silverman,et al.  A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[93]  D. Gisselsson,et al.  Molecular cytogenetic characterization of the 11q13 amplicon in head and neck squamous cell carcinoma , 2006, Cytogenetic and Genome Research.

[94]  D. Albertson,et al.  Chromosome aberrations in solid tumors , 2003, Nature Genetics.

[95]  D. Horsfall,et al.  EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer , 1997, Oncogene.

[96]  M R Speicher,et al.  Quantitative analysis of comparative genomic hybridization. , 1995, Cytometry.

[97]  Thomas Cremer,et al.  Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization , 1993, Human Genetics.

[98]  Alejandro A Schäffer,et al.  Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression , 2002, Genes, chromosomes & cancer.

[99]  A. Hart,et al.  Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. , 1997, Archives of otolaryngology--head & neck surgery.